Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Get Rating) and DarioHealth (NASDAQ:DRIO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership. Valuation & Earnings This table compares Alpha […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its price target lowered by Alliance Global Partners from $7.50 to $6.00 in a report published on Friday, The Fly reports. Separately, Craig Hallum dropped their price target on shares of DarioHealth from $14.00 to $8.00 in a research report on Friday. DarioHealth Price Performance Shares of NASDAQ DRIO […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its target price reduced by Craig Hallum from $14.00 to $8.00 in a report released on Friday, The Fly reports. DarioHealth Stock Performance DarioHealth stock opened at $3.79 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.98 and a current ratio of 3.39. […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its target price lowered by Alliance Global Partners from $7.50 to $6.00 in a research note published on Friday, The Fly reports. Separately, Craig Hallum cut their price target on shares of DarioHealth from $14.00 to $8.00 in a report on Friday. DarioHealth Stock Performance Shares of DarioHealth stock […]
DarioHealth (NASDAQ:DRIO – Get Rating) and Pulmonx (NASDAQ:LUNG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Insider and Institutional Ownership 35.8% of DarioHealth shares are held by […]